Genetics of melanoma predisposition

Oncogene

Volumn 22, Issue 20, 2003, Pages 3053-3062

  Hayward, Nicholas K ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

ARF; CDK4; CDKN2A; MC1R; Penetrance; Pigmentation

Indexed keywords

CYTOCHROME P450 2D6; EPIDERMAL GROWTH FACTOR; GENE PRODUCT; MELANOCORTIN 1 RECEPTOR; VITAMIN D RECEPTOR;

ARF GENE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CDK4 GENE; CDKN2A GENE; CELL DIFFERENTIATION; CELL GROWTH; CYP2D6 GENE; DETOXIFICATION; DNA POLYMORPHISM; DNA REPAIR; EGF GENE; GENE; GENE IDENTIFICATION; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; GSTM1 GENE; HUMAN; MC1R GENE; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN PIGMENTATION; ULTRAVIOLET RADIATION; VDR GENE;

CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYTOCHROME P-450 CYP2D6; EPIDERMAL GROWTH FACTOR; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MELANOMA; MUTATION; PENETRANCE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, CALCITRIOL; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; SKIN PIGMENTATION; TUMOR SUPPRESSOR PROTEIN P14ARF; ULTRAVIOLET RAYS;

EID: 0038795172     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206445     Document Type: Review

References (91)

1. Anonymous (1992). Cancer Incidence in Five Continents. Age-standardized Incidence Rates, Four-Digit Rubrics, and Age-Standardized and Cumulative Incidence Rates, Three-Digit Rubrics. IARC Scientific Publications: Lyon, France, pp. 871-1011.
2. Armstrong BK and English DR. (1996). Cancer Epidemiology and Prevention. Shottenfeld D, Fraumeni JFJ (eds). Oxford University Press: New York, NY, pp. 1282-312.
3. Auroy S, Avril MF, Chompret A, Pham D, Goldstein AM, Bianchi-Scarra G, Frebourg T, Joly P, Spatz A, Rubino C, Demenais F and Bressac-de Paillerets B. (2001). Genes Chromosomes Cancer, 32, 195-202.
4. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AICR). (1999). Cancer in Australia 1996: incidence and mortality data for 1996 and selected data for 1997 and 1998. AIHW (Cancer Series): Canberra, Australia.
5. Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N and Hayward N. (1999). J. Natl. Cancer. Inst., 91, 446-452.
6. Azizi E, Friedman J, Pavlotsky F, Iscovich J, Bornstein A, Shafir R, Trau H, Brenner H and Nass D. (1995). Cancer, 76, 1571-1578.
7. Bahuau M, Vidaud D, Jenkins RB, Bieche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B and Vidaud M. (1998). Cancer Res., 58, 2298-2303.
8. Bahuau M, Vidaud D, Kujas M, Palangie A, Assouline B, Chaignaud-Lebreton M, Prieur M, Vidaud M, Harpey JP, Lafourcade J and Caille B. (1997). Ann. Genet., 40, 78-91.
9. Bastiaens M, ter Huurne J, Gruis N, Bergman W, Westendorp R, Vermeer BJ and Bouwes Bavinck JN. (2001). Hum. Mol. Genet., 10, 1701-1708.
10. Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Paillerets BB, Chompret A, Ghiorzo P, Gruis N, Hansson J, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A and Tucker MA. (2002). J. Natl. Cancer Inst., 94, 894-903.
11. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM, Osterlind A, Walter SD, Peto J, Easton DF, for the International Melanoma Analysis Group (IMAGE). (1995). Int. J. Cancer, 62, 367-376.
12. Borg A, Johannsson U, Johannsson O, Hakansson S, Westerdahl J, Masback A, Olsson H and Ingvar C. (1996) Cancer Res., 56, 2497-2500.
13. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, Westerdahl J, Olsson H and Ingvar C. (2000). J. Natl. Cancer Inst., 92, 1260-1266.
14. Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA and Hayward NK. (2001). Am. J. Hum. Genet., 69, 765-773.
15. Box NF, Wyeth JR, O'Gorman LE, Martin NG and Sturm RA. (1997). Hum. Mol. Genet., 6, 1891-1897.
16. Chenevix-Trench G, Young J, Coggan M and Board P. (1995). Carcinogenesis, 16, 1655-1657.
17. Ciotti P, Strigini P and Bianchi-Scarra G. (1996). N. Engl. J. Med., 334, 469-470.
18. Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarra G, Bressac-de Paillerets B and Goldstein AM. (2000). Am. J. Hum. Genet., 67, 311-319.
19. Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G and Pierotti MA. (2001). Br. J. Cancer, 85, 836-844.
20. Dolzan V, Rudolf Z and Breskvar K. (1995). Carcinogenesis, 16, 2675-2678.
21. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, Neuhausen SL, Ford D, Wooster R, Cannon-Albright LA, Stratton MR and Goldgar DE. (1997). Am. J. Hum. Genet., 61, 120-128.
22. Elwood JM, Whitehead SM, Davison J, Stewart M and Galt M. (1990). Int. J. Epidemiol., 19, 801-810.
23. Foulkes WD, Flanders TY, Pollock PM and Hayward NK. (1997). Mol. Med., 3, 5-20.
24. Ghiorzo P, Ciotti P, Mantelli M, Heouaine A, Queirolo P, Rainero ML, Ferrari C, Santi PL, De Marchi R, Farris A, Ajmar F, Bruzzi P and Bianchi-Scarra G. (1999). Int. J. Cancer, 83, 441-448.
25. Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark Jr WH and Tucker MA. (1995). N. Engl. J. Med., 333, 970-974.
26. Goldstein AM, Liu L, Shennan MG, Hogg D, Tucker MA and Struewing JP. (2001). Br. J. Cancer, 85, 527-530.
27. Goldstein AM, Struewing JP, Chidambaram A, Fraser MC and Tucker MA. (2000). J. Natl. Cancer Inst., 92, 1006-1010.
28. Grammatico P, Binni F, Eibenschutz L, De Bernardo C, Grammatico B, Rinaldi R, De Simone P and Catricala C. (2001). Melanoma Res., 11, 447-449.
29. Gruis NA, Sandkuijl LA, van der Velden PA, Bergman W and Frants RR. (1995). Melanoma Res., 5, 169-177.
30. Harding RM, Healy E, Ray AJ, Ellis NS, Flanagan N, Todd C, Dixon C, Sajantila A, Jackson IJ, Birch-Machin MA and Rees JL. (2000). Am. J. Hum. Genet., 66, 1351-1361.
31. Hashemi J, Bendahl PO, Sandberg T, Platz A, Linder S, Stierner U, Olsson H, Ingvar C, Hansson J and Borg A. (2001). Genes Chromosomes Cancer, 31, 107-116.
32. Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U and Hansson J. (2000) Cancer Res., 60, 6864-6867.
33. Hayward N. (2000). Curr. Oncol. Rep., 2, 300-306.
34. Heagerty AH, Fitzgerald D, Smith A, Bowers B, Jones P, Fryer AA, Zhao L and Alldersea J and Strange RC (1994). Lancet, 343, 266-268.
35. Hewitt C, Lee Wu C, Evans G, Howell A, Elles RG, Jordan R, Sloan P, Read AP and Thakker N. (2002). Hum. Mol. Genet., 11, 1273-1279.
36. Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN, Jones PW, York C, Strange RC and Fryer AA. (2000) Clin. Cancer Res., 6, 498-504.
37. Ichii-Jones F, Lear JT, Heagerty AH, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW, Davies E, Ollier WE, Thomson W, Yengi L, Bath J, Fryer AA and Strange RC, (1998). J. Invest. Dermatol., 111, 218-221.
38. Iscovich J, Abdulrosik M, Cour C, Fischbein A, Pe'er J and Goldgar D. (2002). Int J. Cancer, 98, 42-44.
39. Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A and Rebbeck TR. (2001). Cancer Epidemiol. Biomarkers Prev., 10, 509-513.
40. Kanetsky PA, Swoyer J, Panossian S, Holmes R, Guerry D and Rebbeck TR. (2002). Am. J. Hum. Genet., 70, 770-775.
41. Kaufman DK, Kimmel DW, Parisi JE and Michels VV. (1993). Neurology, 43, 1728-1731.
42. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R and Bavinck JN. (2001). J. Invest. Dermatol., 117, 294-300.
43. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A and Berns A. (2001). Nature, 413, 83-86.
44. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA and Hemminki K. (2001). Int. J. Cancer, 95, 388-393.
45. Lafuente A, Molina R, Palou J, Castel T, Moral A and Trias M. (1995). Br. J. Cancer, 72, 324-326.
46. Lal G, Liu L, Hogg D, Lassam NJ, Redston MS and Gallinger S. (2000a). Genes Chromosomes Cancer, 27, 358-361.
47. Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M and Gallinger S. (2000). Cancer Res., 60, 409-416.
48. Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N and Hogg D. (1999). Nat. Genet., 21, 128-132.
49. Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R and Hogg D. (1995). Oncogene, 11, 405-412.
50. Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, Liu L, Knezetic J, Lassam NJ, Goggins M and Kern S. (2002). Cancer, 94, 84-96.
51. MacKie RM, Andrew N, Lanyon WG and Connor JM. (1998). J. Invest. Dermatol., 111, 269-272.
52. MacLennan R, Green AC, McLeod GR and Martin NG. (1992) J. Natl. Cancer Inst., 84, 1427-1432.
53. Metzelaar-Blok JA, ter Huurne JA, Hurks HM, Keunen JE, Jager MJ and Gruis NA. (2001). Invest. Ophthalmol. Vis. Sci., 42, 1951-1954.
54. Monzon J, Liu L, Brill H, Goldstein AM, Tucker MA, From L, McLaughlin J, Hogg D and Lassam NJ. (1998). N. Engl. J. Med., 338, 879-887.
55. Moskaluk CA, Hruban H, Lietman A, Smyrk T, Fusaro L, Fusaro R, Lynch J, Yeo CJ, Jackson CE, Lynch HT and Kern SE. (1998). Mutations in brief no. 148. Online. Hum. Mutat., 12, 70.
56. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG and Sturm RA. (2000). Am. J. Hum. Genet., 66, 176-186.
57. Pavey S, Conroy S, Russell T and Gabrielli B. (1999). Cancer Res., 59, 4185-4189.
58. Pavey S and Gabrielli B. (2002). Cancer Res., 62, 875-880.
59. Pavey S, Russell T and Gabrielli B. (2001). Oncogene, 20, 6103-6110.
60. Petronzelli F, Sollima D, Coppola G, Martini-Neri ME, Neri G and Genuardi M. (2001). Genes Chromosomes Cancer, 31, 398-401.
61. Petty EM, Gibson LH, Fountain JW, Bolognia JL, Yang-Feng TL, Housman DE and Bale AE. (1993). Am. J. Hum. Genet., 53, 96-104.
62. Platz A, Hansson J, Mansson-Brahme E, Lagerlof B, Linder S, Lundqvist E, Sevigny P, Inganas M and Ringborg U. (1997). J. Natl. Cancer Inst., 89, 697-702.
63. Pollock PM, Spurr N, Bishop T, Newton-Bishop J, Gruis N, van der Velden PA, Goldstein AM, Tucker MA, Foulkes WD, Barnhill R, Haber D, Fountain J and Hayward NK. (1998). Hum. Mutat., 11, 424-431.
64. Randerson-Moor JA, Harland M, Williams S, Cuthbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whitaker L, Knowles M, Bishop JN and Bishop DT. (2001). Hum. Mol. Genet., 10, 55-62.
65. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L and Edwards BK. (eds). (2002). SEER Cancer Statistics Review, 1973_1999. Bethesda, (MD), http://seer.-cancer.gov/csr/1973-1999: National Cancer Institute.
66. Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jimenez L, Mila M and Kefford RF. (2001). Oncogene, 20, 5543-5547.
67. Ruas M and Peters G. (1998). Biochim. Biophys. Acta., 1378, F115-F177.
68. Sauroja I, Smeds J, Vlaykova T, Kumar R, Talve L, Hahka-Kemppinen M, Punnonen K, Jansen CT, Hemminki K and Pyrhonen S. (2000). Genes Chromosomes Cancer, 28, 404-414.
69. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC, Hutchinson PE, Osborne JE, Lear JT, Smith AG and Hutchinson IV. (2002). Lancet., 359, 397-401.
70. Shanley SM, Chenevix-Trench G, Palmer J and Hayward N. (1995). Carcinogenesis, 16, 2003-2004.
71. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW and DePinho RA. (2001). Nature., 413, 86-91.
72. Sinilnikova OM, Egan KM, Quinn JL, Boutrand L, Lenoir GM, Stoppa-Lyonnet D, Desjardins L, Levy C, Goldgar D and Gragoudas ES. (1999). Int. J. Cancer, 82, 325-328.
73. Smith-Sorensen B and Hovig E. (1996). Hum. Mutat., 7, 294-303.
74. Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J and Bressac-de Paillerets B. (1998). Hum. Mol. Genet., 7, 209-216.
75. Strange RC, Ellison T, Ichii-Jones F, Bath J, Hoban P, Lear JT, Smith AG, Hutchinson PE, Osborne J, Bowers B, Jones PW and Fryer AA. (1999). Pharmacogenetics, 9, 269-276.
76. Sturm RA, Box NF and Ramsay M. (1998). Bioessays, 20, 712-721.
77. Sturm RA, Teasdale RD and Box NF. (2001). Gene., 277, 49-62.
78. Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA and Foulkes WD. (1997). Int. J. Cancer, 73, 531-536.
79. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ and Haluska FG. (2000). Arch. Dermatol., 136, 1118-1122.
80. Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry IV D and Clark Jr WH. (1997). JAMA, 277, 1439-1444.
81. Valverde P, Healy E, Jackson I, Rees JL and Thody AJ. (1995). Nat. Genet., 11, 328-330.
82. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, Jackson IJ and Rees JL. (1996). Hum. Mol. Genet., 5, 1663-1666.
83. van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR and Gruis NA. (2001). Am. J. Hum. Genet., 69, 774-779.
84. Whelan AJ, Bartsch D and Goodfellow PJ. (1995). N. Engl. J. Med., 333, 975-977.
85. Whiteman DC, Milligan A, Welch J, Green AC and Hayward NK. (1997). J. Natl. Cancer Inst., 89, 1460.
86. Wolf CR, Smith CA, Gough AC, Moss JE, Vallis KA, Howard G, Carey FJ, Mills K, McNee W, Carmichael J and Spurr N. (1992). Carcinogenesis, 13, 1035-1038.
87. Yakobson E, Shemesh P, Azizi E, Winkler E, Lassam N, Hogg D, Brookes S, Peters G, Lotem M, Zlotogorski A, Landau M, Safro M, Shafir R, Friedman E and Peretz H. (2000). Eur. J. Hum. Genet., 8, 590-596.
88. Yarbrough WG, Aprelikova O, Pei H, Olshan AF and Liu ET. (1996). J. Natl. Cancer Inst., 88, 1489-1491.
89. Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, Martin N and Green A. (2002). Int. J. Cancer, 98, 92-98.
90. Zhang Y and Xiong Y. (1999). Mol. Cell, 3, 579-591.
91. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N and Dracopoli NC. (1996). Nat. Genet., 12, 97-99.